2001
DOI: 10.1038/nbt1101-1029
|View full text |Cite
|
Sign up to set email alerts
|

Polymeric system for dual growth factor delivery

Abstract: The development of tissues and organs is typically driven by the action of a number of growth factors. However, efforts to regenerate tissues (e.g., bone, blood vessels) typically rely on the delivery of single factors, and this may partially explain the limited clinical utility of many current approaches. One constraint on delivering appropriate combinations of factors is a lack of delivery vehicles that allow for a localized and controlled delivery of more than a single factor. We report a new polymeric syst… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

21
1,157
1
6

Year Published

2005
2005
2011
2011

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 1,616 publications
(1,185 citation statements)
references
References 30 publications
21
1,157
1
6
Order By: Relevance
“…One possibility is the use of other angiogenic growth factors (Richardson et al, 2001;Wong et al, 2003). So, in addition to FGF-2, we individually tested platelet derived growth factor-BB (PDGF-BB), vascular endothelial growth factor (VEGF 165 ), and bone morphogenic protein-2 (BMP-2) at 1, 10, and 100 ng/mL, while keeping all other construct components constant.…”
Section: Resultsmentioning
confidence: 99%
“…One possibility is the use of other angiogenic growth factors (Richardson et al, 2001;Wong et al, 2003). So, in addition to FGF-2, we individually tested platelet derived growth factor-BB (PDGF-BB), vascular endothelial growth factor (VEGF 165 ), and bone morphogenic protein-2 (BMP-2) at 1, 10, and 100 ng/mL, while keeping all other construct components constant.…”
Section: Resultsmentioning
confidence: 99%
“…Polymeric systems allow for independent regulation of the localization, duration, and availability of one or more soluble factors [28][29][30], while limiting the overall quantity of drug and minimizing the potential side effects of systemic dosing. Many techniques have been developed to regulate the kinetics and distribution of soluble factors, including multiple levels of encapsulation [31] as well as noncovalently bonding the bioactive factors to peptides with a range of dissociation constants mimicking ECM immobilization of growth factors [32]. With respect to the latter, phage display has been a powerful technique for identifying ligands that can tightly control the kinetics of factor release [32].…”
Section: Spatial and Temporal Control Of Morphogen And Growth Factor mentioning
confidence: 99%
“…With respect to the latter, phage display has been a powerful technique for identifying ligands that can tightly control the kinetics of factor release [32]. Dual delivery of multiple growth factors and morphogens has been achieved in multiple systems including poly (lactide-co-glycolide) (PLG) [31], oligo(poly(ethylene glycol) fumarate) [33], and alginate [34] scaffolds. Multiple factors can be delivered sequentially, simultaneously, or both, and these techniques can be combined with DNA or RNAi delivery to enable long-standing protein expression [35] or abrogation of expression [36].…”
Section: Spatial and Temporal Control Of Morphogen And Growth Factor mentioning
confidence: 99%
See 1 more Smart Citation
“…Different attempts have been already made to release different proteins from a single release system, in the shape of rods [20], hydrogels [21], or gelatin layers [22]. Porous scaffolds as reservoir for multiple proteins were so far obtained only by assembly and fusion of microspheres [23,24] or by associating them with pre-existing porous structures [25]. It is therefore of 0168 interest to investigate new approaches to deliver multiple proteins.…”
Section: Introductionmentioning
confidence: 99%